Anil Kumar Busimi, SCHOTT Pharmaceutical Packaging - Qepler Summits And Conferences

Anil Kumar Busimi

Senior Global Product Manager
SCHOTT Pharmaceutical Packaging
Winterthur, Switzerland
Pharmaceutical Packaging - a top supplier of parenteral packaging | SCHOTT North America

Anil Busimi started his professional career in 2003 at SCHOTT AG in Germany.

He worked in different positions including business development manager for microarrays, project manager for new business, and consultant in corporate strategy and development.

In 2005, he moved to the business segment Pharmaceutical Packaging and played a key role in building long-term business strategy, market intelligence, product management and innovation for pharmaceutical systems business.

From August 2009 until June 2016, he held various positions in global product management for pre-fillable syringe business (glass and polymer).

Currently, he is in the strategy & innovation team as senior global product manager for Cartridges and leads the iQ™ Platform market launch.

He holds M.Sc degree in Agriculture and Genetics and a MBA.

Related Sessions:

Pre-Filled Syringes
Summit 2018

Enhance a fully integrated system approach for developing pre-filled syringes to maintain patient centricity.
  • 31 May 2018
  • Berlin, DE
  • Pharma
Day 2: Friday, 01 June 2018
BLOCK: COMPONENT SELECTION AND PRIMARY PACKAGING.
CASE STUDY: How to prevent needle clogging in PFS by selecting the right needle shield.

It’s a question we hear again and again. A question that has greater importance for pharmaceutical manufacturers as the popularity of prefilled syringes (PFSs) continues to rise and manufacturers must not only develop an effective drug, but a streamlined and safe drug delivery system. A question that shows how pharmaceutical packaging plays a significant role in drug success, even as choosing the “right” packaging material for a drug remains a hot area of debate.

The question is seemingly simple: Is glass or polymer the better material for PFSs? Each has its strengths and weaknesses after all. Ultimately, that is the wrong debate to be having. Before analyzing the benefits and drawbacks of each material, pharmaceutical manufacturers need to start by assessing the user need for each PFS application.

This presentation will discuss the following points:

  • Overview of the PFS market.
  • Review the benefits and limitations of glass PFS.
  • Options for polymers PFS on the market.
  • Benefits and limitations of polymer PFS.
  • How can pharma companies choose the best option for their product.
  • Based on case studies I will highlight what needs to be considering for making choice between glass or polymer PFS.
View Details

2nd Annual Pre-Filled
Syringes Summit 2019

Enhance expertise sharing in developing pre-filled syringes and provide attendees with ample networking opportunities.
  • 04 Jun 2019
  • Barcelona, ES
  • Pharma
Day 2: Wednesday, 05 June 2019
BLOCK: COMPONENT SELECTION AND RISK MITIGATION STRATEGIES.
CASE STUDY: Innovative Pre-Filled Syringe (PFS) Solutions for Biotech Drugs.
  • The R&D pipeline of global pharma industry is full with biotech-based drugs making personalized medicine a reality.
  • Most of these drugs are target specific and highly sensitive demanding special attention to all the steps along the development process and value chain.
  • Biotech drugs are complex molecules and may interact with the components of the PFS (needle, glue, silicone, elastomer etc.) leading to stability issues, impact efficacy of the drug and worst cases immunogenic response in patients
  • Prefilled syringes are an enabler for market trend hospital to home administration for injectable drugs.
  • This presentation will share the solutions and risk mitigation approaches for pre-fillable syringes.
  • It also discusses pros and cons of glass vs. polymer and what is the right choice?
View Details